Invited scientists who - most of them - had accepted to lecture already in the year 2005;

but for a more detailed day-by-day programme click here

Eddy Arnold++, Rutgers University, NJ, USA
Heather Baker, University of Auckland, New Zealand
Ted Baker, University of Auckland, New Zealand
Terese Bergfors, University of Uppsala, Sweden
Tom Blundell, Cambridge University, UK
Phil Bourne+, UCSD, CA, USA
Daniel Bur*, Actelion, Basel, Switzerland
Christian Cambillau**, CNRS, Marseille, France
Sandra Jacob, Novartis, Basel, Switzerland
Gabriele Cruciani, University of Perugia, Italy
Tom Davies+++, Astex Therapeutics, Cambridge, UK
Paula Fitzgerald***, Merck, Rahway, USA
Colin Groom, UCB, Cambridge, UK
John Irwin, UCSF, CA, USA
Gerhard Klebe, University of Marburg, Germany
Joseph Marcotrigiano++, Rutgers University, NJ, USA
Vincent Mikol, Sanofi-Aventis, Vitry-sur-Seine, France
Jay Pandit, Pfizer, Groton, USA
Richard Pauptit, AstraZeneca, Macclesfield, UK
Peter Rose++++, UCSD, CA, USA
Michael Rossmann, Purdue University, IN, USA
Andrej Sali, UCSF, CA, USA
Giovanna Scapin, Merck, Rahway, USA
Helen Saibil, Birkbeck College, London, UK
Brian Shoichet, UCSF, CA, USA
Joel Sussman, Weizmann Institute, Rehovot, Israel
Janet Thornton****, EBI, Hinxton, UK
Dusan Turk, Jozef Stefan Institute, Ljubljana, Slovenia
James D. Watson++, EBI, Hinxton, UK
Bill Weis++, Stanford University, USA
Ada Yonath, Weizmann Institute, Rehovot, Israel
+added Fall 2007, withdrawn April 30, 2008 due to professional commitments
++added Jan 2008
+++added March 13, 2008
++++added April 30, 2008 as suggested by Phil Bourne, unable to join
*withdrawn early Dec 2007, due to professional reasons
**withdrawn early Nov 2007 due to change in research theme
***withdrawn begin March 2008 for personal reasons
**** withdrawn on Jan 23, due to official commitments required by her top-bureaucratic role

Topics.
Fundamentals of molecular recognition
Using structure to select drug targets
Structure assisted hit identification
The beta2 adrenergic receptor
Crystallographic assessment of high throughput screening hits
Modelling flexible ligands into flexible proteins
Ligand binding site description, comparison, discovery
High throughput protein crystallography
Emerging tools for drug design
Biological therapeutics
Integrated biophysical studies of macromolecules
Towards complete atomic maps of organisms
From biological molecules to biological systems
Structure based drug design
Structural genomics
Bioinformatics
Automatization of access to databases.